JCO at ASCO Annual Meeting: Lenvatinib Plus Pembrolizumab and Chemotherapy in Gastric Cancer

<p><em>JCO</em> Editorial Fellow Dr. Peter Li and <em>JCO</em> Associate Editor Dr. Andrew Ko discuss the ASCO 25 Simultaneous Publication paper "<a href= "https://ascopubs.org/doi/10.1200/JCO-25-00748" target="_blank" rel="noopener">Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III Randomized LEAP-015 Study</a>."</p> <h2>Transcript</h2> <p class="MsoNormal" style= "text-align: center; margin: 12.0pt 0in 12.0pt 0in;" align= "center"><em style="mso-bidi-font-style: normal;"><span lang="EN" xml:lang="EN">The guest on this podcast episode has no disclosures to declare.</span></em></p> <p class="MsoNormal" style="margin: 12.0pt 0in 12.0pt 0in;"> <strong><span style="mso-ansi-language: EN-US;">Dr. Peter Li:</span></strong> <span style="mso-ansi-language: EN-US;">Hello, everyone, and welcome to our 2025 ASCO Annual Meeting Series where we cover some of the top <em>JCO</em> papers published simultaneously w...